Sofosbuvir
API’s Name：Sofosbuvir
CAS No.：1190307-88-0
Indication：HCV
Innovator：In-House
Specification：
US DMF：32048
EU DMF：√
CEP：
Only for R&D purpose
Product Detail
Intermediates
Code | CAS | Specification |
SFBM | 1256490-31-9 | In-House |
SFB-8 | 874638-80-9 | In-House |
SFB-10 | 817204-32-3 | In-House |
SFBA-1 | 863329-66-2 | In-House |
SFBMA | 1334513-02-8 | In-House |
Generic Name: sofosbuvir (soe FOS bue vir)
Brand Names: Sovaldi
Sofosbuvir is an antiviral medicine that is used to treat chronic hepatitis C in adults and children who are at least 3 years old and an HCV RNA replication inhibitor with an EC50 of 92 nM.
Sofosbuvir must be given in combination with other antiviral medications (usually ribavirin with or without peginterferon alfa). Sofosbuvir should not be used alone.
Sofosbuvir treats specific genotypes of hepatitis C, and only in certain people. Use only the medications prescribed for you. Do not share your medicine with other people.
Sofosbuvir is sometimes used in people who also have HIV, or people who have liver cancer and are going to have a liver transplant. This medicine is not a treatment for HIV or AIDS.
Storage
| Powder | -20°C | 3 years |
4°C | 2 years | |
| In solvent | -80°C | 6 months |
-20°C | 1 month |
Chemical structure
